JANX EPS Estimates
Janux Therapeutics, Inc.
$18.39
-$0.11(-0.59%)
66
Overall
60
Value
90
Tech
50
Quality
Market Cap
$1.12B
Volume
1.17M
52W Range
$12.12 - $35.34
Target Price
$30.94
JANX EPS estimates: the consensus estimate for Janux Therapeutics, Inc.'s current fiscal year is -$1.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
JANX EPS Estimates
- EPS estimate, current quarter
- $-0.45
- EPS estimate, next quarter
- $-0.55
- EPS estimate, current year
- $-1.70
- EPS estimate, next year
- $-2.64
- EPS growth, 3-year
- -6.38%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.83 |
| 2024 | $-1.28 |
| 2023 | $-1.32 |
| 2022 | $-1.52 |
| 2021 | $-1.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JANX | $18.39 | -0.6% | 1.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Janux Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW